Could nurses replace doctors for TB treatment? major trial underway

NCT ID NCT05671718

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study compares nurse-led treatment for drug-resistant tuberculosis (TB) in local clinics to standard doctor-led care in hospitals. About 2,944 people will take part across South Africa. The goal is to see if nurse-led care works just as well, is safe, and lowers costs for patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Doris Goodwin Hospital

    RECRUITING

    Pietermaritzburg, KwaZulu-Natal, 3201, South Africa

    Contact

  • Jose Pearson Hospital

    RECRUITING

    Port Elizabeth, South Africa

    Contact

  • King Dinuzulu TB Hospital

    RECRUITING

    East London, South Africa

    Contact

  • Murchison Hospital

    RECRUITING

    Port Shepstone, KwaZulu-Natal, 7007, South Africa

    Contact

  • Nkquebela TB Hospital

    RECRUITING

    East London, South Africa

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nurse-led treatment (care delivery model)

What this could lead to

If successful, this could make drug-resistant TB treatment more accessible and affordable by shifting care from hospitals to local clinics.

What could go wrong

This is a large trial but still early in testing a new care model. Results may vary by location, and nurse-led care might not match hospital safety or outcomes.

Conditions

The condition(s) this trial relates to.

AIDS drug-resistant tuberculosis multidrug-resistant tuberculosis rifampicin-resistant tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.